The iShares Morningstar Small-Cap Growth ETF (ISCG) charges a lower expense ratio than the Invesco S&P SmallCap 600 Pure Growth ETF (RZG).
RZG has delivered higher total returns over the past one- and five-year periods.
ISCG provides broader diversification with more than 900 holdings, compared to 125 for RZG.
The iShares Morningstar Small-Cap Growth ETF (NYSEMKT:ISCG) provides a low-cost, highly diversified approach to small-cap growth, while the Invesco S&P SmallCap 600 Pure Growth ETF (NYSEMKT:RZG) offers a more concentrated strategy.
Both funds target the small-cap growth segment but build their portfolios in different ways. ISCG follows a traditional market-cap-weighted index of small companies, while RZG screens the S&P SmallCap 600 for stocks with the strongest growth characteristics -- such as sales growth, earnings momentum, and price momentum -- and weights its holdings accordingly.
| Metric | RZG | ISCG |
|---|---|---|
| Issuer | Invesco | iShares |
| Expense ratio | 0.35% | 0.06% |
| 1-year return (as of July 9, 2026) | 38.84% | 27.53% |
| Dividend yield | 0.42% | 0.57% |
| Beta | 1.04 | 1.22 |
| AUM | $135.9 million | $1.0 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
ISCG is significantly cheaper, with an expense ratio of 0.06%, compared to RZG’s 0.35%. ISCG also offers a slightly higher dividend yield of 0.57%, compared to RZG's 0.42% -- a modest edge for income-minded investors.
| Metric | RZG | ISCG |
|---|---|---|
| Max drawdown (5 yr) | (38.33%) | (41.47%) |
| Growth of $1,000 over 5 years (total return) | $1,375 | $1,298 |
Launched in 2004, ISCG tracks a broad index of small-cap growth stocks. The fund has heavy concentrations in industrials and technology at 23.9% and 22.5%, respectively, as well as healthcare at 17.9%. With 933 holdings, it offers extensive diversification, minimizing individual stock risk. Its largest positions include Sterling Infrastructure (NASDAQ:STRL) at 0.8%, Okta (NASDAQ:OKTA) at 0.7%, and Guardant Health (NASDAQ:GH) at 0.6%.
RZG provides a narrower portfolio of 125 stocks, built from the S&P SmallCap 600 index. This index uses a growth-score methodology that favors companies with strong sales growth, earnings momentum, and price momentum. Its top sector allocations are healthcare at 25.1%, technology at 17.3%, and industrials at 16.4%. RZG’s approach leads to higher concentration than ISCG's, with top holdings including ACM Research (NASDAQ:ACMR) at 3.7%, Powell Industries (NASDAQ:POWL) at 2.0%, and Argan (NYSE:AGX) at 2.0%. RZG fund was launched in 2006.
For more guidance on ETF investing, check out the full guide at this link.
The choice between these two funds really comes down to how much an investor is willing to pay for the potential to outperform.
Cost is almost always a primary consideration when two funds target a similar corner of the market. ISCG's 0.06% expense ratio is about as cheap as small-cap investing gets -- on a $10,000 investment, ISCG charges roughly $6 a year, versus about $35 a year for RZG. Over long holding periods, that fee gap can compound meaningfully.
That said, RZG's recent outperformance isn't surprising given the type of stocks it holds. By concentrating on companies already showing strong sales and earnings momentum, growth-oriented funds like RZG tend to do well when those trends stay intact -- but that same concentration can cut both ways if momentum fades or a handful of its largest holdings stumble. ISCG's broader, market-cap-weighted approach spreads that risk across more than 900 companies, trading some upside potential for more diversified exposure to the small-cap growth space.
Investors who want the cheapest, most diversified way to own small-cap growth stocks may lean toward ISCG, while those comfortable with more concentrated bets on recent momentum, and willing to pay more for it, may find RZG's recent track record more appealing. As with any small-cap allocation, these funds are probably best used as a slice of a diversified portfolio rather than a core holding, given the added volatility that comes with smaller companies.
Before you buy stock in iShares Trust - iShares Morningstar Small-Cap Growth ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Morningstar Small-Cap Growth ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $395,679!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,294,805!*
Now, it’s worth noting Stock Advisor’s total average return is 929% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of July 13, 2026.
Andy Gould has positions in Sterling Infrastructure. The Motley Fool has positions in and recommends Guardant Health, Okta, and Sterling Infrastructure. The Motley Fool has a disclosure policy.